Hoffman La Roche

Roche expects “relatively low” growth of 5% this year

Hoffman La Roche pharmaceutical giant, the second biggest player on the Romanian drug market, for this year has budgeted a “relatively low” increase of 5%, compared with the level of around 700m RON (167m euros) reached in 2009.